159 related articles for article (PubMed ID: 10379740)
1. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
[TBL] [Abstract][Full Text] [Related]
2. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.
Van den Abbeele AD; Tutrone RF; Berman RM; Baranowska-Kortylewicz J; Barclay PD; Richie JP; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Feb; 37(2):315-20. PubMed ID: 8667069
[TBL] [Abstract][Full Text] [Related]
4. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeled iododeoxyuridine: safety evaluation.
Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
[TBL] [Abstract][Full Text] [Related]
6. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
[TBL] [Abstract][Full Text] [Related]
7. The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer.
Yamamoto Y; Nasu Y; Saika T; Akaeda T; Tsushima T; Kumon H
BJU Int; 2000 Nov; 86(7):802-4. PubMed ID: 11069404
[TBL] [Abstract][Full Text] [Related]
8. Systemic absorption and pharmacokinetics of single-dose early intravesical mitomycin C after transurethral resection of non-muscle-invasive bladder cancer.
Maffezzini M; Campodonico F; Manuputty EE; Puntoni M; Martelli A; Marini V; Tamagno S; Mattioli F
Urology; 2013 Aug; 82(2):400-4. PubMed ID: 23791221
[TBL] [Abstract][Full Text] [Related]
9. Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy.
Chinol M; De Cobelli O; Trifirò G; Scardino E; Bartolomei M; Verweij F; Papi S; Matei DV; Paganelli G
Eur Urol; 2003 Nov; 44(5):556-9. PubMed ID: 14572754
[TBL] [Abstract][Full Text] [Related]
10. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
[TBL] [Abstract][Full Text] [Related]
11. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.
Hughes OD; Bishop MC; Perkins AC; Wastie ML; Denton G; Price MR; Frier M; Denley H; Rutherford R; Schubiger PA
J Clin Oncol; 2000 Jan; 18(2):363-70. PubMed ID: 10637251
[TBL] [Abstract][Full Text] [Related]
12. [Serum uptake of doxorubicin intravesically administered soon after transurethral resection of bladder carcinoma].
Nagakura K; Takao M; Odajima K; Ieda K; Fujioka T; Hayakawa M; Murai M; Nakamura H
Hinyokika Kiyo; 1989 Sep; 35(9):1509-12. PubMed ID: 2816617
[TBL] [Abstract][Full Text] [Related]
13. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
Semnani ES; Wang K; Adelstein SJ; Kassis AI
J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
[TBL] [Abstract][Full Text] [Related]
14. On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swine.
Baranowska-Kortylewicz J; Dalrymple GV; Harrison KA; Holdeman KP; Sharp JG; Cohen SM; Lieberman RP; Schneiderman MH; Clausen SR; Hoffman D; Lai J; Schneiderman GS; Helseth L
Acta Oncol; 1996; 35(7):925-33. PubMed ID: 9004773
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
Dalton JT; Wientjes MG; Badalament RA; Drago JR; Au JL
Cancer Res; 1991 Oct; 51(19):5144-52. PubMed ID: 1913640
[TBL] [Abstract][Full Text] [Related]
17. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. II. On the effects of intravesical instillation of cis-diamminedichloroplatinum in bladder cancer patients].
Hirao Y; Iwai A; Moriya A; Matsuki H; Yoshida Y; Komada S; Sasaki K; Kubota K; Sanma S; Babaya K
Hinyokika Kiyo; 1985 Sep; 31(9):1565-73. PubMed ID: 4083214
[TBL] [Abstract][Full Text] [Related]
18. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.
Blasberg RG; Roelcke U; Weinreich R; Beattie B; von Ammon K; Yonekawa Y; Landolt H; Guenther I; Crompton NE; Vontobel P; Missimer J; Maguire RP; Koziorowski J; Knust EJ; Finn RD; Leenders KL
Cancer Res; 2000 Feb; 60(3):624-35. PubMed ID: 10676646
[TBL] [Abstract][Full Text] [Related]
19. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
Li Q; Xu T; Wang XF
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]